Skip to main content

New blood-drug monitoring platform receives €10M funding


The platform will first be used to measure the concentration of beta-lactam antibiotics – used to treat or prevent bacterial infections – in a patient’s blood. (Image: Pexels/Karolina Grabowska)

The platform, which employs therapeutic drug monitoring and optical technology, could pave the way for personalised and faster care

Welcome to Electro optics

Already registered?  Sign in to continue reading

Not got an account?  Register for free to continue reading

Media Partners